I think the issue you're having on this one stems from the fact that you've misidentified the flaw in the argument.
We know that standard treatments are effective and that nonstandard treatments are ineffective. There is a guaranteed split and everything is either standard and effective or nonstandard and ineffective. So the gap in the reasoning that you identified
ldanny24 Wrote:The problem I'm having is that the stimulus goes from Standard Methods to ALL effective treatments. It makes a sort of jump. The stimulus doesn't include whether other forms of treatment were being used. Maybe there was a third option that was the most effective and money had been consistently poured to that one.
isn't really a concern.
The conclusion of this argument is that less money is being spent on effective treatments (which we learn are the standard ones) for a certain disease than 10 years ago. Why? Because a greater percent of money spent on treatment for that disease is going to ineffective treatments.
The flaw in the argument is that the evidence relies on percentages, while the conclusion is about an amount. This is a common flaw that appears on the LSAT. Think of it this way... Would you rather have 10% of $10,000,000 or 90% of $1.
We don't know based on the argument how much is being spent on disease X overall. Suppose the total amount being spent on treating disease X increased dramatically. Then it's possible that even though a greater proportion of the total money is now going to ineffective treatments, the amount going to effective treatments actually increased. Here are some numbers to flush out that scenario:
Total for disease X 10 years ago: $100,000
Percentage for standard: 70%
Percentage for nonstandard: 30%
Amount for standard: $70,000
Amount for nonstandard: $30,000
Total for disease X today: $1,000,000
Percentage for standard: 50%
Percentage for nonstandard: 50%
Amount for standard: $500,000
Amount for nonstandard: $500,000
The great thing about answer choice (E) is that it corrects for this oversight in the argument.
(A) is confusing but irrelevant. It seems like this answer is saying that less money is being spent on treatment, similar to (E), but instead it talks about how common different varieties of the disease are-and we don't know that this or that variety's rate of occurrence will affect treatment rates. For all we know, regardless of diminishing occurrences, the rate of treatment can go up because of increased public awareness.
(B) is tricky! If nonstandard/ineffective are more expensive, won't less money get spent on the standard ones? It depends on how much money is spent in general on treatment, and how much more expensive the nonstandard becomes. We're still in the dark about the total amounts spent.
(C) is about how much was spent on the disease in general, in relation to total medical spending. This could mean that total spending went down, or that spending on disease X went up. Either way doesn't help the argument.
(D) is tempting. If 50+% was spent on nonstandard, it must be that less money went to standard, right? No! What if total spending on disease X quadruple-dupled?